Min Su Kang, Adjia Hamadjida, Dominique Bédard, Stephen G Nuara, Jim C Gourdon, Stephen Frey, Arturo Aliaga, Karen Ross, Robert Hopewell, Hussein Bdair, Axel Mathieu, Christine Lucas Tardif, Jean-Paul Soucy, Gassan Massarweh, Pedro Rosa-Neto, Philippe Huot
JNJ-42491293 is a metabotropic glutamate 2 (mGlu2 ) positive allosteric modulator (PAM) that was radiolabelled with [11 C]- to serve as a positron emission tomography (PET) ligand. Indeed, in vitro, the molecule displays high selectivity at mGlu2 receptors. However, PET experiments performed in rats, macaques and humans, have suggested that [11 C]-JNJ-42491293 could interact with an unidentified, non-mGlu2 receptor binding site. The brain distribution of [11 C]-JNJ-42491293 has not been determined in the brain of the common marmoset, a small non-human primate increasingly used in neuroscience research...
March 16, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology